APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mobile In-Home NAD IV Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mobile In-Home NAD IV Therapy Market Outlook and Growth Opportunities 2026

29 December 2025205 pages

Choose your research edition.

Industry ResearchMobile In-Home NAD IV Therapy Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Mobile In-Home NAD IV Therapy Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Mobile In-Home NAD IV Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mobile In-Home NAD IV Therapy Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Mobile In-Home NAD IV Therapy Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Mobile In-Home NAD IV Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mobile In-Home NAD IV Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mobile In-Home NAD IV Therapy market include Toronto Functional Medicine Centre, Thedripclub, The Wellness Lab, Seaside Skin Care, Rocky Mountain Ivmedics, Reset IV, Premiumhealth, Nadclinic and Mobileivmedics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mobile In-Home NAD IV Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mobile In-Home NAD IV Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mobile In-Home NAD IV Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mobile In-Home NAD IV Therapy market.

Mobile In-Home NAD IV Therapy Segment by Company

Toronto Functional Medicine Centre

Thedripclub

The Wellness Lab

Seaside Skin Care

Rocky Mountain Ivmedics

Reset IV

Premiumhealth

Nadclinic

Mobileivmedics

LIVV Natural

IV Boost UK

Hydrate IV Bar

Effect Doctors

Conciergemdla

BioReset Medical

Azivmedics

Mobile In-Home NAD IV Therapy Segment by Type

NAD+ Mixed Vitamin Injections

Pure NAD+ Injection

Mobile In-Home NAD IV Therapy Segment by Application

Clinic

Hospital

Home

Mobile In-Home NAD IV Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mobile In-Home NAD IV Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mobile In-Home NAD IV Therapy key companies, revenue, market share, and recent developments.

3. To split the Mobile In-Home NAD IV Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mobile In-Home NAD IV Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mobile In-Home NAD IV Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Mobile In-Home NAD IV Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mobile In-Home NAD IV Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mobile In-Home NAD IV Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mobile In-Home NAD IV Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mobile In-Home NAD IV Therapy industry.

Chapter 3: Detailed analysis of Mobile In-Home NAD IV Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mobile In-Home NAD IV Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mobile In-Home NAD IV Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mobile In-Home NAD IV Therapy Industry Trends Table 2. Mobile In-Home NAD IV Therapy Industry Drivers Table 3. Mobile In-Home NAD IV Therapy Industry Opportunities and Challenges Table 4. Mobile In-Home NAD IV Therapy Industry Restraints Table 5. Global Mobile In-Home NAD IV Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mobile In-Home NAD IV Therapy Revenue Share by Company (2021-2026) Table 7. Global Mobile In-Home NAD IV Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mobile In-Home NAD IV Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Mobile In-Home NAD IV Therapy Company, Product Type & Application Table 10. Global Mobile In-Home NAD IV Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mobile In-Home NAD IV Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of NAD+ Mixed Vitamin Injections Table 15. Significant Companies of Pure NAD+ Injection Table 16. Global Mobile In-Home NAD IV Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Mobile In-Home NAD IV Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Mobile In-Home NAD IV Therapy Sales Value Share by Type (2021-2026) Table 20. Global Mobile In-Home NAD IV Therapy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinic Table 22. Significant Companies of Hospital Table 23. Significant Companies of Home Table 24. Global Mobile In-Home NAD IV Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Mobile In-Home NAD IV Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Mobile In-Home NAD IV Therapy Sales Value Share by Application (2021-2026) Table 28. Global Mobile In-Home NAD IV Therapy Sales Value Share by Application (2027-2032) Table 29. Global Mobile In-Home NAD IV Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Mobile In-Home NAD IV Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Mobile In-Home NAD IV Therapy Sales Value Share by Region (2021-2026) Table 32. Global Mobile In-Home NAD IV Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Mobile In-Home NAD IV Therapy Sales Value Share by Region (2027-2032) Table 34. Global Mobile In-Home NAD IV Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Mobile In-Home NAD IV Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Mobile In-Home NAD IV Therapy Sales Value Market Share by Country (2021-2026) Table 37. Global Mobile In-Home NAD IV Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Mobile In-Home NAD IV Therapy Sales Value Market Share by Country (2027-2032) Table 39. Toronto Functional Medicine Centre Company Information Table 40. Toronto Functional Medicine Centre Business Overview Table 41. Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Product Portfolio Table 43. Toronto Functional Medicine Centre Recent Development Table 44. Thedripclub Company Information Table 45. Thedripclub Business Overview Table 46. Thedripclub Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Thedripclub Mobile In-Home NAD IV Therapy Product Portfolio Table 48. Thedripclub Recent Development Table 49. The Wellness Lab Company Information Table 50. The Wellness Lab Business Overview Table 51. The Wellness Lab Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. The Wellness Lab Mobile In-Home NAD IV Therapy Product Portfolio Table 53. The Wellness Lab Recent Development Table 54. Seaside Skin Care Company Information Table 55. Seaside Skin Care Business Overview Table 56. Seaside Skin Care Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Seaside Skin Care Mobile In-Home NAD IV Therapy Product Portfolio Table 58. Seaside Skin Care Recent Development Table 59. Rocky Mountain Ivmedics Company Information Table 60. Rocky Mountain Ivmedics Business Overview Table 61. Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Product Portfolio Table 63. Rocky Mountain Ivmedics Recent Development Table 64. Reset IV Company Information Table 65. Reset IV Business Overview Table 66. Reset IV Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Reset IV Mobile In-Home NAD IV Therapy Product Portfolio Table 68. Reset IV Recent Development Table 69. Premiumhealth Company Information Table 70. Premiumhealth Business Overview Table 71. Premiumhealth Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Premiumhealth Mobile In-Home NAD IV Therapy Product Portfolio Table 73. Premiumhealth Recent Development Table 74. Nadclinic Company Information Table 75. Nadclinic Business Overview Table 76. Nadclinic Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nadclinic Mobile In-Home NAD IV Therapy Product Portfolio Table 78. Nadclinic Recent Development Table 79. Mobileivmedics Company Information Table 80. Mobileivmedics Business Overview Table 81. Mobileivmedics Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mobileivmedics Mobile In-Home NAD IV Therapy Product Portfolio Table 83. Mobileivmedics Recent Development Table 84. LIVV Natural Company Information Table 85. LIVV Natural Business Overview Table 86. LIVV Natural Mobile In-Home NAD IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. LIVV Natural Mobile In-Home NAD IV Therapy Product Portfolio Table 88. LIVV Natural Recent Development Table 89. IV Boost UK Company Information Table 90. IV Boost UK Business Overview Table 91. IV Boost UK Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. IV Boost UK Mobile In-Home NAD IV Therapy Product Portfolio Table 93. IV Boost UK Recent Development Table 94. Hydrate IV Bar Company Information Table 95. Hydrate IV Bar Business Overview Table 96. Hydrate IV Bar Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hydrate IV Bar Mobile In-Home NAD IV Therapy Product Portfolio Table 98. Hydrate IV Bar Recent Development Table 99. Effect Doctors Company Information Table 100. Effect Doctors Business Overview Table 101. Effect Doctors Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Effect Doctors Mobile In-Home NAD IV Therapy Product Portfolio Table 103. Effect Doctors Recent Development Table 104. Conciergemdla Company Information Table 105. Conciergemdla Business Overview Table 106. Conciergemdla Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Conciergemdla Mobile In-Home NAD IV Therapy Product Portfolio Table 108. Conciergemdla Recent Development Table 109. BioReset Medical Company Information Table 110. BioReset Medical Business Overview Table 111. BioReset Medical Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. BioReset Medical Mobile In-Home NAD IV Therapy Product Portfolio Table 113. BioReset Medical Recent Development Table 114. Azivmedics Company Information Table 115. Azivmedics Business Overview Table 116. Azivmedics Mobile In-Home NAD IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Azivmedics Mobile In-Home NAD IV Therapy Product Portfolio Table 118. Azivmedics Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Mobile In-Home NAD IV Therapy Product Image Figure 2. Global Mobile In-Home NAD IV Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mobile In-Home NAD IV Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Mobile In-Home NAD IV Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. NAD+ Mixed Vitamin Injections Image Figure 8. Pure NAD+ Injection Image Figure 9. Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Mobile In-Home NAD IV Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Mobile In-Home NAD IV Therapy Sales Value Share by Type (2021-2032) Figure 12. Clinic Image Figure 13. Hospital Image Figure 14. Home Image Figure 15. Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mobile In-Home NAD IV Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mobile In-Home NAD IV Therapy Sales Value Share by Application (2021-2032) Figure 18. Global Mobile In-Home NAD IV Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Mobile In-Home NAD IV Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Mobile In-Home NAD IV Therapy Sales Value (2021-2032) & (US$ Million) Figure 21. North America Mobile In-Home NAD IV Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Mobile In-Home NAD IV Therapy Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Mobile In-Home NAD IV Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Mobile In-Home NAD IV Therapy Sales Value (2021-2032) & (US$ Million) Figure 27. South America Mobile In-Home NAD IV Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • NAD+ Mixed Vitamin Injections
  • Pure NAD+ Injection
Applications
  • Clinic
  • Hospital
  • Home
Companies covered
  • Toronto Functional Medicine Centre
  • Thedripclub
  • The Wellness Lab
  • Seaside Skin Care
  • Rocky Mountain Ivmedics
  • Reset IV
  • Premiumhealth
  • Nadclinic
  • Mobileivmedics
  • LIVV Natural
  • IV Boost UK
  • Hydrate IV Bar
  • Effect Doctors
  • Conciergemdla
  • BioReset Medical
  • Azivmedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mobile In-Home NAD IV Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mobile In-Home NAD IV Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mobile In-Home NAD IV Therapy Market Dynamics
  1. 2.1 Mobile In-Home NAD IV Therapy Industry Trends
  2. 2.2 Mobile In-Home NAD IV Therapy Industry Drivers
  3. 2.3 Mobile In-Home NAD IV Therapy Industry Opportunities and Challenges
  4. 2.4 Mobile In-Home NAD IV Therapy Industry Restraints
3 Mobile In-Home NAD IV Therapy Market by Company
  1. 3.1 Global Mobile In-Home NAD IV Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Mobile In-Home NAD IV Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Mobile In-Home NAD IV Therapy Company Ranking (2024-2026)
  4. 3.4 Global Mobile In-Home NAD IV Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Mobile In-Home NAD IV Therapy Company Product Type and Application
  6. 3.6 Global Mobile In-Home NAD IV Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mobile In-Home NAD IV Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mobile In-Home NAD IV Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mobile In-Home NAD IV Therapy Market by Type
  1. 4.1 Mobile In-Home NAD IV Therapy Type Introduction
  2. 4.1.1 NAD+ Mixed Vitamin Injections
  3. 4.1.2 Pure NAD+ Injection
  4. 4.2 Global Mobile In-Home NAD IV Therapy Sales Value by Type
  5. 4.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Mobile In-Home NAD IV Therapy Sales Value Share by Type (2021-2032)
5 Mobile In-Home NAD IV Therapy Market by Application
  1. 5.1 Mobile In-Home NAD IV Therapy Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Home
  5. 5.2 Global Mobile In-Home NAD IV Therapy Sales Value by Application
  6. 5.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mobile In-Home NAD IV Therapy Sales Value Share by Application (2021-2032)
6 Mobile In-Home NAD IV Therapy Regional Value Analysis
  1. 6.1 Global Mobile In-Home NAD IV Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mobile In-Home NAD IV Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
7 Mobile In-Home NAD IV Therapy Country-level Value Analysis
  1. 7.1 Global Mobile In-Home NAD IV Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Toronto Functional Medicine Centre
  2. 8.1.1 Toronto Functional Medicine Centre Company Information
  3. 8.1.2 Toronto Functional Medicine Centre Business Overview
  4. 8.1.3 Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Product Portfolio
  6. 8.1.5 Toronto Functional Medicine Centre Recent Developments
  7. 8.2 Thedripclub
  8. 8.2.1 Thedripclub Company Information
  9. 8.2.2 Thedripclub Business Overview
  10. 8.2.3 Thedripclub Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thedripclub Mobile In-Home NAD IV Therapy Product Portfolio
  12. 8.2.5 Thedripclub Recent Developments
  13. 8.3 The Wellness Lab
  14. 8.3.1 The Wellness Lab Company Information
  15. 8.3.2 The Wellness Lab Business Overview
  16. 8.3.3 The Wellness Lab Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 The Wellness Lab Mobile In-Home NAD IV Therapy Product Portfolio
  18. 8.3.5 The Wellness Lab Recent Developments
  19. 8.4 Seaside Skin Care
  20. 8.4.1 Seaside Skin Care Company Information
  21. 8.4.2 Seaside Skin Care Business Overview
  22. 8.4.3 Seaside Skin Care Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Seaside Skin Care Mobile In-Home NAD IV Therapy Product Portfolio
  24. 8.4.5 Seaside Skin Care Recent Developments
  25. 8.5 Rocky Mountain Ivmedics
  26. 8.5.1 Rocky Mountain Ivmedics Company Information
  27. 8.5.2 Rocky Mountain Ivmedics Business Overview
  28. 8.5.3 Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Product Portfolio
  30. 8.5.5 Rocky Mountain Ivmedics Recent Developments
  31. 8.6 Reset IV
  32. 8.6.1 Reset IV Company Information
  33. 8.6.2 Reset IV Business Overview
  34. 8.6.3 Reset IV Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Reset IV Mobile In-Home NAD IV Therapy Product Portfolio
  36. 8.6.5 Reset IV Recent Developments
  37. 8.7 Premiumhealth
  38. 8.7.1 Premiumhealth Company Information
  39. 8.7.2 Premiumhealth Business Overview
  40. 8.7.3 Premiumhealth Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Premiumhealth Mobile In-Home NAD IV Therapy Product Portfolio
  42. 8.7.5 Premiumhealth Recent Developments
  43. 8.8 Nadclinic
  44. 8.8.1 Nadclinic Company Information
  45. 8.8.2 Nadclinic Business Overview
  46. 8.8.3 Nadclinic Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nadclinic Mobile In-Home NAD IV Therapy Product Portfolio
  48. 8.8.5 Nadclinic Recent Developments
  49. 8.9 Mobileivmedics
  50. 8.9.1 Mobileivmedics Company Information
  51. 8.9.2 Mobileivmedics Business Overview
  52. 8.9.3 Mobileivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mobileivmedics Mobile In-Home NAD IV Therapy Product Portfolio
  54. 8.9.5 Mobileivmedics Recent Developments
  55. 8.10 LIVV Natural
  56. 8.10.1 LIVV Natural Company Information
  57. 8.10.2 LIVV Natural Business Overview
  58. 8.10.3 LIVV Natural Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LIVV Natural Mobile In-Home NAD IV Therapy Product Portfolio
  60. 8.10.5 LIVV Natural Recent Developments
  61. 8.11 IV Boost UK
  62. 8.11.1 IV Boost UK Company Information
  63. 8.11.2 IV Boost UK Business Overview
  64. 8.11.3 IV Boost UK Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 IV Boost UK Mobile In-Home NAD IV Therapy Product Portfolio
  66. 8.11.5 IV Boost UK Recent Developments
  67. 8.12 Hydrate IV Bar
  68. 8.12.1 Hydrate IV Bar Company Information
  69. 8.12.2 Hydrate IV Bar Business Overview
  70. 8.12.3 Hydrate IV Bar Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hydrate IV Bar Mobile In-Home NAD IV Therapy Product Portfolio
  72. 8.12.5 Hydrate IV Bar Recent Developments
  73. 8.13 Effect Doctors
  74. 8.13.1 Effect Doctors Company Information
  75. 8.13.2 Effect Doctors Business Overview
  76. 8.13.3 Effect Doctors Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Effect Doctors Mobile In-Home NAD IV Therapy Product Portfolio
  78. 8.13.5 Effect Doctors Recent Developments
  79. 8.14 Conciergemdla
  80. 8.14.1 Conciergemdla Company Information
  81. 8.14.2 Conciergemdla Business Overview
  82. 8.14.3 Conciergemdla Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Conciergemdla Mobile In-Home NAD IV Therapy Product Portfolio
  84. 8.14.5 Conciergemdla Recent Developments
  85. 8.15 BioReset Medical
  86. 8.15.1 BioReset Medical Company Information
  87. 8.15.2 BioReset Medical Business Overview
  88. 8.15.3 BioReset Medical Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BioReset Medical Mobile In-Home NAD IV Therapy Product Portfolio
  90. 8.15.5 BioReset Medical Recent Developments
  91. 8.16 Azivmedics
  92. 8.16.1 Azivmedics Company Information
  93. 8.16.2 Azivmedics Business Overview
  94. 8.16.3 Azivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Azivmedics Mobile In-Home NAD IV Therapy Product Portfolio
  96. 8.16.5 Azivmedics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst